J07BN04 COVID-19, protein subunit
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 3 drugs in this drug class.
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J07 Vaccines 119 drugs
- J07B Viral vaccines 78 drugs
- J07BN04 COVID-19, protein subunit 3 drugs
- J07B Viral vaccines 78 drugs
- J07 Vaccines 119 drugs
Active ingredients of the class
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Covifenz PM | – |
| Nuvaxovid (Novavax) PM | – |
| Nuvaxovid (Sanofi Vaccines Canada) PM | – |
Other classes of the same level
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J07BN04
Ask your doctor or pharmacist for advice.